Dr Matthew Nichols, MD | |
10103 Ridgegate Pkwy Ste 312, Lone Tree, CO 80124-5525 | |
(303) 788-8888 | |
(866) 456-4594 |
Full Name | Dr Matthew Nichols |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 24 Years |
Location | 10103 Ridgegate Pkwy Ste 312, Lone Tree, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952451379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 41703 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sky Ridge Medical Center | Lone tree, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
South Denver Gastroenterology, P.c | 2062302508 | 47 |
News Archive
Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival.
Researchers have found that there a numerous transposons or "jumping genes" within the genetic code that is responsible for development of the embryo and its growth. These were earlier thought to be junk or useless parts of the genome.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.
› Verified 9 days ago
Entity Name | South Denver Gastroenterology, P.c |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447364831 PECOS PAC ID: 2062302508 Enrollment ID: O20040317001558 |
News Archive
Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival.
Researchers have found that there a numerous transposons or "jumping genes" within the genetic code that is responsible for development of the embryo and its growth. These were earlier thought to be junk or useless parts of the genome.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Nichols, MD 10103 Ridgegate Pkwy Ste 312, Lone Tree, CO 80124-5525 Ph: (303) 788-8888 | Dr Matthew Nichols, MD 10103 Ridgegate Pkwy Ste 312, Lone Tree, CO 80124-5525 Ph: (303) 788-8888 |
News Archive
Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival.
Researchers have found that there a numerous transposons or "jumping genes" within the genetic code that is responsible for development of the embryo and its growth. These were earlier thought to be junk or useless parts of the genome.
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.
› Verified 9 days ago
Dr. John Paul Wilkins, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Dr. Michael Alan Rocklin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9777 S Yosemite St Ste 110, Lone Tree, CO 80124 Phone: 720-696-0852 Fax: 720-696-0892 | |
Dr. Baran Aksut, BARAN AKSUT M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10103 Ridgegate Pkwy Ste 103, Lone Tree, CO 80124 Phone: 303-645-0090 Fax: 303-645-0092 | |
Dr. James Thomas Link, M. D., PHD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Abigail Turnbough, Gastroenterology Medicare: Medicare Enrolled Practice Location: 10099 Ridgegate Pkwy Ste 200, Lone Tree, CO 80124 Phone: 720-476-3364 Fax: 720-875-2877 | |
Kenji Kaye, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9695 S Yosemite St Ste 224, Lone Tree, CO 80124 Phone: 303-265-3970 Fax: 206-320-8048 | |
Dr. Anna K.d. Gutmann, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 303-338-4545 |